Connect Biopharma Holdings Ltd (CNTB) Form 10-K Annual Reports
Connect Biopharma Holdings Ltd (CNTB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CNTB
CIK: 1835268
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerJin Dong
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-06 | — | SCHEDULE 13G Filing | 0001373604-26-000057 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | FORM 4 | 0002115875-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | FORM 4 | 0001835268-26-000039 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001835268-26-000038 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001835268-26-000034 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352971 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001913491-26-000005 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001835268-26-000028 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001835268-26-000027 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001835268-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001835268-26-000021 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-05-29 | 4 | 0001193125-26-253607 | View SEC Doc Filr Page |
| EFFECT | 2026-06-01 | — | EFFECT Filing | 9999999995-26-001825 | View SEC Doc Filr Page |
| CORRESP | 2026-05-28 | — | CORRESP Filing | 0001193125-26-245157 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-22 | — | UPLOAD Filing | 0000000000-26-005249 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001913491-26-000003 | View SEC Doc Filr Page |
| F-3 | 2026-05-15 | — | F-3 | 0001193125-26-225436 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001835268-26-000020 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001835268-26-000019 | View SEC Doc Filr Page |
| 8-K | 2026-04-23 | 2026-04-23 | 8-K | 0001835268-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-14 | — | SCHEDULE 13G Filing | 0001912836-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | FORM 4 | 0002115875-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-04-02 | 2026-03-31 | FORM 4 | 0001241357-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-31 | 4 | 0001193125-26-138012 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-01 | — | SCHEDULE 13D/A Filing | 0001193125-26-138013 | View SEC Doc Filr Page |